Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development.

Nguyen L, Pieters J.

Annu Rev Pharmacol Toxicol. 2009;49:427-53. doi: 10.1146/annurev-pharmtox-061008-103123. Review.

PMID:
19281311
2.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

[Prospects for development of new antituberculous drugs].

Tomioka H.

Kekkaku. 2002 Aug;77(8):573-84. Japanese.

PMID:
12235850
5.

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.

Almeida Da Silva PE, Palomino JC.

J Antimicrob Chemother. 2011 Jul;66(7):1417-30. doi: 10.1093/jac/dkr173. Epub 2011 May 9. Review.

PMID:
21558086
6.

Challenges in the development of drugs for the treatment of tuberculosis.

Shehzad A, Rehman G, Ul-Islam M, Khattak WA, Lee YS.

Braz J Infect Dis. 2013 Jan-Feb;17(1):74-81. doi: 10.1016/j.bjid.2012.10.009. Epub 2013 Jan 1. Review.

7.

Mechanisms of drug resistance in Mycobacterium tuberculosis.

Wade MM, Zhang Y.

Front Biosci. 2004 Jan 1;9:975-94. Review.

PMID:
14766424
8.

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K, van Soolingen D, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2010 Dec;65(12):2582-9. doi: 10.1093/jac/dkq374. Epub 2010 Oct 14.

PMID:
20947621
9.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
10.

Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.

Le Chevalier F, Cascioferro A, Majlessi L, Herrmann JL, Brosch R.

Future Microbiol. 2014;9(8):969-85. doi: 10.2217/fmb.14.70. Review.

PMID:
25302954
11.

Extensively drug-resistant tuberculosis: current challenges and threats.

Jain A, Mondal R.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):145-50. doi: 10.1111/j.1574-695X.2008.00400.x. Epub 2008 May 8. Review.

12.

Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.

Bailo R, Bhatt A, AĆ­nsa JA.

Biochem Pharmacol. 2015 Aug 1;96(3):159-67. doi: 10.1016/j.bcp.2015.05.001. Epub 2015 May 16. Review.

PMID:
25986884
13.

Novel targets in M. tuberculosis: search for new drugs.

Lamichhane G.

Trends Mol Med. 2011 Jan;17(1):25-33. doi: 10.1016/j.molmed.2010.10.004. Epub 2010 Nov 9. Review.

PMID:
21071272
14.

Preclinical testing of new drugs for tuberculosis: current challenges.

Lenaerts AJ, Degroote MA, Orme IM.

Trends Microbiol. 2008 Feb;16(2):48-54. doi: 10.1016/j.tim.2007.12.002. Epub 2008 Jan 7.

PMID:
18182291
15.

Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.

Palomino JC, Martin A, Von Groll A, Portaels F.

J Microbiol Methods. 2008 Oct;75(2):161-6. doi: 10.1016/j.mimet.2008.06.015. Epub 2008 Jun 25. Review.

PMID:
18627779
16.

Mycobacterium tuberculosis: drug resistance and future perspectives.

Riccardi G, Pasca MR, Buroni S.

Future Microbiol. 2009 Jun;4(5):597-614. doi: 10.2217/fmb.09.20. Review.

PMID:
19492969
17.

Current status and future development of antitubercular chemotherapy.

Kremer LS, Besra GS.

Expert Opin Investig Drugs. 2002 Aug;11(8):1033-49. Review.

PMID:
12150700
18.

Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.

Tomioka H, Tatano Y, Sano C, Shimizu T.

J Infect Chemother. 2011 Jun;17(3):302-17. doi: 10.1007/s10156-010-0177-y. Epub 2011 Jan 18. Review.

PMID:
21243398
20.

[Active drugs against Mycobacterium tuberculosis].

Coll P.

Enferm Infecc Microbiol Clin. 2009 Oct;27(8):474-80. doi: 10.1016/j.eimc.2009.06.010. Epub 2009 Sep 18. Review. Spanish.

PMID:
19766360

Supplemental Content

Support Center